A new study shows risks for premature death associated with CUD. Others show increased memory problems, CUD, depression, ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...

A new cohort study found that schizophrenia cases related to cannabis use disorder serious enough to warrant a person to seek emergency care increased afte ...

The Food and Drug Administration (FDA) has granted Fast Track designation to PP-01 (nabilone/gabapentin) for the mitigation of cannabis withdrawal ...

Although surveys have found that few clinicians discuss cannabis use with their patients, experts make the case why they ...

2024 — Nearly one in six patients in primary care reported cannabis use, with 35% of those using at levels indicating moderate- to high-risk use disorder. The findings indicate the need for ...

A new study suggests that people who visit the emergency department (ED) due to cannabis use may have a much higher risk of developing anxiety disorders. Within three years, 27% of these individuals ...

Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, discusses the bidirectional relationship between schizophrenia and ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A new study from Canadian researchers has found that the proportion of new schizophrenia cases associated with cannabis use ...

A study in Ontario found that schizophrenia cases linked to cannabis use disorder have more than doubled since cannabis ...